PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsSK Life Science
SK Life Science
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
XcopriCenobamate2020-03-102032-2039
Epilepsy
,
Partial epilepsies
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Cenobamate
healthy volunteers/patients
,
drug misuse
,
liver diseases
,
hepatic insufficiency
,
partial epilepsies
,
generalized epilepsy
,
seizures
,
epilepsy
Carisbamate
healthy volunteers/patients
,
diabetic neuropathies
,
neuralgia
,
herpes zoster
,
postherpetic neuralgia
,
essential tremor
,
tremor
,
movement disorders
,
peripheral nervous system diseases
,
polyneuropathies
,
mononeuropathies
,
drug resistant epilepsy
,
migraine disorders
,
headache
,
epilepsy
,
seizures
,
partial epilepsies
,
complex partial epilepsy
,
lennox gastaut syndrome
,
syndrome
,
partial epilepsy motor
RELENOPRIDE
constipation
Skl24741
healthy volunteers/patients
Ccb
diabetic neuropathies
Antacid
healthy volunteers/patients
Wellbutrin
healthy volunteers/patients
Kcl
healthy volunteers/patients
Zyban
healthy volunteers/patients
Pbo
epilepsy
,
seizures
,
generalized epilepsy
Skl11197
peripheral nervous system diseases
,
diabetic neuropathies
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use